NHS England publishes Biosimilar Workshop Report on NHS Network
In March 2016, NHS England, in coordination with a range of national partners, hosted two workshops on biosimilar medicines.
Attendees included local stakeholders with decision-making responsibility for commissioning, prescribing, dispensing and monitoring biological medicine, including biosimilar medicines, alongside patient representatives.
Drawing on their vast range of experiences, attendees engaged in peer to peer discussions, debate and learning. Conversations were informed by presentations on national and international biosimilars developments, as well as local stakeholder panels featuring healthcare professionals.
The recently published report of the events summarises these discussions and includes 12 proposed next steps and 30 suggested actions for consideration arising from the day.